FDA Holds Workshop on Mobile Medical Applications Draft Guidance

The U.S. Food and Drug Administration recently held a public workshop on its Mobile Medical Applications Draft Guidance that was released in July, according to an FDA announcement.

Advertisement

The workshop was designed to foster discussion about the FDA’s draft guidance for mobile medical applications and encourage public comment from stakeholders. Specific topics the FDA wanted to address included aspects of the draft guidance. The FDA also sought feedback on how it should approach accessories and standalone software that provide clinical decision support.

Comments on the draft guidance are due by Oct. 19.

Related Articles on Mobile Health Applications:

AMA Names 10 Finalists in App Challenge
Wisconsin’s Gundersen Lutheran, Cincinnati’s St. Elizabeth Healthcare Launch Mobile Apps

Carolinas HealthCare System Develops Mobile App to Improve Access to Care

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Health IT

Advertisement

Comments are closed.